GlassScriptPhysician profile
Margaret Harris
NPI 1811696339
$1,039.18
in general payments reported to CMS, 2019-2025
16 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $652 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $314.90 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $184.24 | 2024-2025 | |
| Astellas Pharma US INC | $91.93 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $82.88 | 2025 | |
| Abbvie INC. | $65.14 | 2024-2025 | |
| Exeltis, USA INC. | $54.50 | 2024 | Slynd |
| Organon LLC | $50.78 | 2024 | |
| Millicent US INC | $44.08 | 2025 | Femlyv, Intrarosa |
| Amgen INC. | $36.41 | 2024-2025 | Evenity, Prolia |
| Radius Health, INC. | $18.55 | 2025 | Tymlos |
| Pacira Pharmaceuticals Incorporated | $18.17 | 2024 | Exparel |
| Pfizer INC. | $17.82 | 2024 | |
| Hologic Sales and Service, LLC | $15.62 | 2024 | Aptima |
| Exact Sciences Corporation | $15.12 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.80 | 2024 | Zepbound |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.